{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T04:28:14Z","timestamp":1783225694489,"version":"3.54.6"},"reference-count":19,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T00:00:00Z","timestamp":1649203200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Laboratory Analysis"],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The clinical significance of serum collagen triple helix repeat protein\u20101 (CTHRC1) and mitotic spindle apparatus antibody (MSA) in the diagnosis of small cell lung cancer (SCLC).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Of the 229\u00a0lung tumor patients selected, 62 patients were divided into SCLC, 94 patients with non\u2010small cell lung cancer (NSCLC), and 73 patients with benign lung disease (BLD). The health controls (HC) had a span of 66 cases with normal physical condition. The serum extracted from each participator and enzyme\u2010linked immunosorbent assay was adopted for measuring the serum CTHRC1 and MSA; in the meantime, automatic electrochemiluminescence immunoassay was used for the quantitative determination of serum NSA and CEA. And then, the differences in serum CTHRC1, MSA, NSE, and CEA were compared among involved groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>\u2460 Compared with other groups, the concentrations of CTHRC1, MSA, and NSE showed a marked increase in the group of SCLC (all <jats:italic>p<\/jats:italic>\u00a0&lt;\u00a00.01). Especially for SCLC patients with lymph node metastasis, CTHRC1 provided a notably higher level than those without metastasis. \u2461 CTHRC1 and MSA established a diagnostic criterion with the specificity of 90.99% and 86.27% for SCLC, respectively. \u2462 In series, the specificity of CTHRC1 and NSE was the highest (99.30%), while MSA and NSE had the highest sensitivity (96.72%) in parallel. \u2463 Both CTHRC1 and MSA were hazardous factors interconnected with SCLC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Serum CTHRC1 and MSA had a more exciting prospect of application. When used in conjunction with NSE and CEA, they could optimize the clinical diagnosis value of SCLC.<\/jats:p><\/jats:sec>","DOI":"10.1002\/jcla.24412","type":"journal-article","created":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T11:19:39Z","timestamp":1649243979000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Application of collagen triple helix repeat containing\u20101 and mitotic spindle apparatus antibody in small cell lung cancer diagnosis"],"prefix":"10.1002","volume":"36","author":[{"given":"Yuhan","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory The Second Affiliated Hospital of Nanchang University  Nanchang China"},{"name":"Jiangxi Province Key Laboratory of Laboratory Medicine  Nanchang China"},{"name":"Graduate Students in the School of Public Health of Nanchang University  Nanchang China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory The Second Affiliated Hospital of Nanchang University  Nanchang China"},{"name":"Jiangxi Province Key Laboratory of Laboratory Medicine  Nanchang China"},{"name":"Graduate Students in the School of Public Health of Nanchang University  Nanchang China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory The Second Affiliated Hospital of Nanchang University  Nanchang China"},{"name":"Jiangxi Province Key Laboratory of Laboratory Medicine  Nanchang China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory The Second Affiliated Hospital of Nanchang University  Nanchang China"},{"name":"Jiangxi Province Key Laboratory of Laboratory Medicine  Nanchang China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianlin","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory The Second Affiliated Hospital of Nanchang University  Nanchang China"},{"name":"Jiangxi Province Key Laboratory of Laboratory Medicine  Nanchang China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory The Second Affiliated Hospital of Nanchang University  Nanchang China"},{"name":"Jiangxi Province Key Laboratory of Laboratory Medicine  Nanchang China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory The Second Affiliated Hospital of Nanchang University  Nanchang China"},{"name":"Jiangxi Province Key Laboratory of Laboratory Medicine  Nanchang China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1888-3476","authenticated-orcid":false,"given":"Liming","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory The Second Affiliated Hospital of Nanchang University  Nanchang China"},{"name":"Jiangxi Province Key Laboratory of Laboratory Medicine  Nanchang China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,4,6]]},"reference":[{"issue":"1","key":"e_1_2_9_2_1","first-page":"26","article-title":"Treatment for small cell lung cancer, where are we now?\u2010A review","volume":"5","author":"Alvarado\u2010Luna G","year":"2016","journal-title":"Transl Lung Cancer Res"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S187317"},{"issue":"2","key":"e_1_2_9_4_1","first-page":"21","article-title":"The clinical significance of anti\u2010mitotic spindle apparatus antibody (MSA) and anti\u2010centromere antibody (ACA) detected in patients with small cell lung cancer (SCLC)","volume":"6","author":"Tan L","year":"2017","journal-title":"Am J Clin Exp Immunol"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2421"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.21037\/qims.2018.08.02"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2019.10.001"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492"},{"issue":"6","key":"e_1_2_9_9_1","first-page":"814","article-title":"Cancer\u2010associated fibroblast\u2010secreted collagen triple helix repeat containing\u20101 promotes breast cancer cell migration, invasiveness and epithelial\u2010mesenchymal transition by activating the Wnt\/beta\u2010catenin pathway","volume":"22","author":"Li H","year":"2021","journal-title":"Oncol Lett"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S219429"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-021-01827-0"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2020.02.098"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9578701"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.3727\/096504016X14685034103716"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4317-6"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2020-0981"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S313440"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2011.08.004"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2020.12.034"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-5002(00)00131-8"}],"container-title":["Journal of Clinical Laboratory Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jcla.24412","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jcla.24412","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jcla.24412","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:32:14Z","timestamp":1692837134000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcla.24412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,6]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["10.1002\/jcla.24412"],"URL":"https:\/\/doi.org\/10.1002\/jcla.24412","archive":["Portico"],"relation":{},"ISSN":["0887-8013","1098-2825"],"issn-type":[{"value":"0887-8013","type":"print"},{"value":"1098-2825","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,6]]},"assertion":[{"value":"2022-02-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e24412"}}